Biktarvy, formally known as bictegravir, represents a potent single-tablet therapy for treating HIV infection. This medication combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the the viral ability to copy within the body, considerably decreasing the viral burden. For many individu